Gene Symbol | Gene ID | Gene Info |
---|---|---|
GFI1B
|
ENSG00000165702.8 | growth factor independent 1B transcriptional repressor |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr9_135878087_135878238 | GFI1B | 16119 | 0.118013 | -0.73 | 2.4e-02 | Click! |
chr9_135869581_135869732 | GFI1B | 7613 | 0.130711 | -0.70 | 3.5e-02 | Click! |
chr9_135858887_135859038 | GFI1B | 3081 | 0.167435 | -0.70 | 3.6e-02 | Click! |
chr9_135855020_135855171 | GFI1B | 997 | 0.421283 | -0.69 | 4.0e-02 | Click! |
chr9_135857688_135857882 | GFI1B | 3687 | 0.152893 | -0.63 | 6.6e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr9_21558261_21558438 | 1.81 |
MIR31HG |
MIR31 host gene (non-protein coding) |
1319 |
0.44 |
chr7_42645149_42645379 | 1.81 |
C7orf25 |
chromosome 7 open reading frame 25 |
306245 |
0.01 |
chr12_59312903_59313092 | 1.72 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
330 |
0.87 |
chr4_187646262_187646501 | 1.56 |
FAT1 |
FAT atypical cadherin 1 |
1372 |
0.58 |
chr6_86160997_86161214 | 1.45 |
NT5E |
5'-nucleotidase, ecto (CD73) |
1278 |
0.58 |
chrX_53078377_53078712 | 1.45 |
GPR173 |
G protein-coupled receptor 173 |
79 |
0.97 |
chr3_29323996_29324173 | 1.45 |
RBMS3 |
RNA binding motif, single stranded interacting protein 3 |
977 |
0.62 |
chr22_46478545_46478698 | 1.44 |
FLJ27365 |
hsa-mir-4763 |
2429 |
0.15 |
chr3_149801405_149801614 | 1.40 |
ENSG00000243321 |
. |
5891 |
0.21 |
chr3_114119404_114119777 | 1.39 |
ZBTB20-AS1 |
ZBTB20 antisense RNA 1 |
13074 |
0.21 |
chr21_17796431_17796623 | 1.36 |
ENSG00000207638 |
. |
114882 |
0.06 |
chr2_216301575_216301809 | 1.34 |
AC012462.1 |
|
716 |
0.48 |
chr5_59783926_59784223 | 1.33 |
PDE4D |
phosphodiesterase 4D, cAMP-specific |
171 |
0.97 |
chr3_150066038_150066370 | 1.33 |
TSC22D2 |
TSC22 domain family, member 2 |
59918 |
0.14 |
chr12_59265576_59265746 | 1.32 |
LRIG3 |
leucine-rich repeats and immunoglobulin-like domains 3 |
2693 |
0.36 |
chr3_149373565_149373716 | 1.31 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
1167 |
0.38 |
chr1_163038601_163039117 | 1.29 |
RGS4 |
regulator of G-protein signaling 4 |
76 |
0.98 |
chr7_55086291_55086580 | 1.27 |
EGFR |
epidermal growth factor receptor |
279 |
0.95 |
chr11_89224254_89224444 | 1.26 |
NOX4 |
NADPH oxidase 4 |
50 |
0.99 |
chrX_103381032_103381192 | 1.24 |
SLC25A53 |
solute carrier family 25, member 53 |
20596 |
0.16 |
chr10_10953626_10954104 | 1.23 |
CELF2 |
CUGBP, Elav-like family member 2 |
93394 |
0.08 |
chr1_185704958_185705157 | 1.22 |
HMCN1 |
hemicentin 1 |
1374 |
0.57 |
chr15_63337269_63337696 | 1.21 |
TPM1 |
tropomyosin 1 (alpha) |
1507 |
0.37 |
chr5_15500207_15500358 | 1.21 |
FBXL7 |
F-box and leucine-rich repeat protein 7 |
23 |
0.99 |
chr1_32168262_32168423 | 1.21 |
COL16A1 |
collagen, type XVI, alpha 1 |
1426 |
0.34 |
chr12_30949792_30950072 | 1.20 |
CAPRIN2 |
caprin family member 2 |
42047 |
0.19 |
chr11_12697523_12698245 | 1.19 |
TEAD1 |
TEA domain family member 1 (SV40 transcriptional enhancer factor) |
834 |
0.75 |
chr14_102302430_102302761 | 1.18 |
CTD-2017C7.1 |
|
3273 |
0.21 |
chr1_35754106_35754533 | 1.17 |
ENSG00000240374 |
. |
3780 |
0.18 |
chr5_122493680_122494140 | 1.17 |
AC106786.1 |
|
67916 |
0.1 |
chr17_81067326_81067613 | 1.17 |
METRNL |
meteorin, glial cell differentiation regulator-like |
15475 |
0.24 |
chr11_121975812_121976123 | 1.14 |
RP11-166D19.1 |
|
90 |
0.96 |
chr5_121411093_121411244 | 1.13 |
LOX |
lysyl oxidase |
2812 |
0.31 |
chr4_20257540_20257840 | 1.13 |
SLIT2 |
slit homolog 2 (Drosophila) |
1147 |
0.67 |
chr4_4854789_4855427 | 1.10 |
MSX1 |
msh homeobox 1 |
6285 |
0.29 |
chr5_170024900_170025159 | 1.10 |
CTC-265N9.1 |
|
83412 |
0.09 |
chr15_86163319_86163521 | 1.10 |
RP11-815J21.3 |
|
7500 |
0.15 |
chr5_155754238_155754771 | 1.09 |
SGCD |
sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) |
737 |
0.81 |
chr5_150325496_150325780 | 1.08 |
ZNF300P1 |
zinc finger protein 300 pseudogene 1 |
213 |
0.94 |
chr3_149373320_149373471 | 1.08 |
WWTR1-AS1 |
WWTR1 antisense RNA 1 |
1412 |
0.33 |
chr12_76653631_76654077 | 1.08 |
ENSG00000223273 |
. |
55677 |
0.14 |
chr10_52752095_52752246 | 1.06 |
PRKG1 |
protein kinase, cGMP-dependent, type I |
1052 |
0.64 |
chr12_114843211_114843442 | 1.05 |
TBX5 |
T-box 5 |
563 |
0.78 |
chr10_35105469_35105702 | 1.05 |
PARD3-AS1 |
PARD3 antisense RNA 1 |
890 |
0.52 |
chr1_7130330_7130574 | 1.05 |
RP11-334N17.1 |
|
56113 |
0.15 |
chr12_13350846_13351208 | 1.05 |
EMP1 |
epithelial membrane protein 1 |
1307 |
0.55 |
chr16_56667294_56667600 | 1.04 |
MT1M |
metallothionein 1M |
828 |
0.29 |
chr3_49169788_49170138 | 1.04 |
LAMB2 |
laminin, beta 2 (laminin S) |
490 |
0.65 |
chr2_23819189_23819442 | 1.04 |
KLHL29 |
kelch-like family member 29 |
45947 |
0.18 |
chr1_98514742_98514981 | 1.04 |
ENSG00000225206 |
. |
3134 |
0.4 |
chr1_39572596_39572941 | 1.04 |
MACF1 |
microtubule-actin crosslinking factor 1 |
1685 |
0.35 |
chr11_12399801_12400294 | 1.03 |
PARVA |
parvin, alpha |
901 |
0.64 |
chr21_17652326_17652785 | 1.02 |
ENSG00000201025 |
. |
4534 |
0.36 |
chr7_54956069_54956673 | 1.02 |
ENSG00000252054 |
. |
22860 |
0.25 |
chr3_100711576_100712203 | 1.00 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
408 |
0.89 |
chr15_33011706_33011883 | 1.00 |
GREM1 |
gremlin 1, DAN family BMP antagonist |
1589 |
0.4 |
chr3_64209595_64209746 | 0.97 |
PRICKLE2 |
prickle homolog 2 (Drosophila) |
1461 |
0.46 |
chr9_100069234_100069583 | 0.97 |
CCDC180 |
coiled-coil domain containing 180 |
533 |
0.83 |
chr2_235861878_235862318 | 0.97 |
SH3BP4 |
SH3-domain binding protein 4 |
1378 |
0.62 |
chr5_31193803_31195028 | 0.95 |
CDH6 |
cadherin 6, type 2, K-cadherin (fetal kidney) |
558 |
0.85 |
chr4_138455145_138455297 | 0.95 |
PCDH18 |
protocadherin 18 |
1573 |
0.58 |
chr13_93879365_93880233 | 0.95 |
GPC6 |
glypican 6 |
704 |
0.82 |
chr5_66254826_66254999 | 0.94 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
96 |
0.98 |
chr17_48132523_48133080 | 0.94 |
ITGA3 |
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) |
538 |
0.71 |
chr4_111558170_111558322 | 0.94 |
PITX2 |
paired-like homeodomain 2 |
64 |
0.99 |
chr2_238035569_238035720 | 0.94 |
COPS8 |
COP9 signalosome subunit 8 |
41058 |
0.15 |
chr5_141595832_141596208 | 0.93 |
SPRY4 |
sprouty homolog 4 (Drosophila) |
107727 |
0.06 |
chr10_33622034_33622426 | 0.92 |
NRP1 |
neuropilin 1 |
1080 |
0.63 |
chr3_66139685_66140118 | 0.92 |
SLC25A26 |
solute carrier family 25 (S-adenosylmethionine carrier), member 26 |
20616 |
0.25 |
chr4_169554219_169554371 | 0.92 |
PALLD |
palladin, cytoskeletal associated protein |
1527 |
0.43 |
chr2_238116736_238116905 | 0.92 |
AC112715.2 |
Uncharacterized protein |
48914 |
0.16 |
chr5_6732608_6732814 | 0.92 |
PAPD7 |
PAP associated domain containing 7 |
17966 |
0.25 |
chr7_27152802_27153012 | 0.92 |
HOXA3 |
homeobox A3 |
557 |
0.38 |
chr3_125321989_125322196 | 0.91 |
OSBPL11 |
oxysterol binding protein-like 11 |
8158 |
0.22 |
chr14_50490583_50491073 | 0.91 |
C14orf182 |
chromosome 14 open reading frame 182 |
16590 |
0.16 |
chr3_149356078_149356269 | 0.91 |
WWTR1-IT1 |
WWTR1 intronic transcript 1 (non-protein coding) |
11798 |
0.17 |
chr18_77906051_77906465 | 0.90 |
AC139100.2 |
Uncharacterized protein |
326 |
0.89 |
chr17_42906288_42907233 | 0.90 |
GJC1 |
gap junction protein, gamma 1, 45kDa |
302 |
0.85 |
chr21_17442706_17442989 | 0.90 |
ENSG00000252273 |
. |
35018 |
0.24 |
chr7_42533422_42533764 | 0.89 |
GLI3 |
GLI family zinc finger 3 |
256935 |
0.02 |
chr1_18192837_18193085 | 0.89 |
ACTL8 |
actin-like 8 |
111153 |
0.07 |
chr4_183064801_183065567 | 0.89 |
AC108142.1 |
|
143 |
0.83 |
chr11_114237888_114238168 | 0.89 |
RP11-64D24.2 |
|
10735 |
0.15 |
chr5_36608256_36608472 | 0.89 |
SLC1A3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
67 |
0.99 |
chr17_36902558_36902709 | 0.89 |
PCGF2 |
polycomb group ring finger 2 |
248 |
0.78 |
chr13_33779104_33779430 | 0.89 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
876 |
0.67 |
chr15_56204998_56205389 | 0.89 |
NEDD4 |
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase |
2659 |
0.34 |
chr17_38255735_38256962 | 0.88 |
NR1D1 |
nuclear receptor subfamily 1, group D, member 1 |
630 |
0.6 |
chr11_102981029_102981283 | 0.88 |
DYNC2H1 |
dynein, cytoplasmic 2, heavy chain 1 |
852 |
0.65 |
chr1_177139870_177140730 | 0.88 |
BRINP2 |
bone morphogenetic protein/retinoic acid inducible neural-specific 2 |
333 |
0.89 |
chr11_46307450_46307608 | 0.87 |
CREB3L1 |
cAMP responsive element binding protein 3-like 1 |
8301 |
0.18 |
chr2_17721828_17722425 | 0.87 |
VSNL1 |
visinin-like 1 |
163 |
0.97 |
chr5_92943123_92943644 | 0.87 |
ENSG00000251725 |
. |
13111 |
0.2 |
chr11_75274364_75274515 | 0.87 |
SERPINH1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
28 |
0.97 |
chr5_110406345_110406728 | 0.86 |
TSLP |
thymic stromal lymphopoietin |
776 |
0.67 |
chr2_219472134_219472377 | 0.86 |
PLCD4 |
phospholipase C, delta 4 |
233 |
0.86 |
chr2_19221096_19221271 | 0.86 |
ENSG00000266738 |
. |
327007 |
0.01 |
chr18_53087965_53088125 | 0.85 |
TCF4 |
transcription factor 4 |
1541 |
0.45 |
chr1_229524899_229525061 | 0.85 |
ENSG00000252506 |
. |
6105 |
0.16 |
chr12_27709290_27709441 | 0.85 |
PPFIBP1 |
PTPRF interacting protein, binding protein 1 (liprin beta 1) |
18309 |
0.22 |
chr9_2838300_2838770 | 0.85 |
KIAA0020 |
KIAA0020 |
5706 |
0.3 |
chr17_15312712_15312879 | 0.84 |
ENSG00000239888 |
. |
1094 |
0.54 |
chr2_230993548_230993699 | 0.84 |
AC009950.2 |
|
3597 |
0.26 |
chr20_59826813_59827194 | 0.84 |
CDH4 |
cadherin 4, type 1, R-cadherin (retinal) |
479 |
0.9 |
chr11_101981627_101982145 | 0.84 |
YAP1 |
Yes-associated protein 1 |
306 |
0.88 |
chr17_15209957_15210211 | 0.84 |
ENSG00000200437 |
. |
4578 |
0.19 |
chr5_81341593_81341802 | 0.84 |
ATG10-AS1 |
ATG10 antisense RNA 1 |
27824 |
0.16 |
chr8_87051491_87051698 | 0.83 |
PSKH2 |
protein serine kinase H2 |
30332 |
0.19 |
chr13_107186025_107186496 | 0.83 |
EFNB2 |
ephrin-B2 |
1202 |
0.59 |
chr19_18497753_18498116 | 0.83 |
ENSG00000264175 |
. |
562 |
0.48 |
chr2_238578863_238579079 | 0.83 |
LRRFIP1 |
leucine rich repeat (in FLII) interacting protein 1 |
21817 |
0.19 |
chr2_19202600_19202769 | 0.83 |
ENSG00000266738 |
. |
345506 |
0.01 |
chr9_684288_685148 | 0.83 |
RP11-130C19.3 |
|
837 |
0.67 |
chr3_73776409_73776793 | 0.83 |
PDZRN3 |
PDZ domain containing ring finger 3 |
102510 |
0.07 |
chr18_56531788_56532358 | 0.83 |
ZNF532 |
zinc finger protein 532 |
20 |
0.98 |
chr10_49812568_49813319 | 0.83 |
ARHGAP22 |
Rho GTPase activating protein 22 |
54 |
0.98 |
chr10_102278895_102279852 | 0.83 |
SEC31B |
SEC31 homolog B (S. cerevisiae) |
218 |
0.92 |
chr1_63154994_63155145 | 0.82 |
RP11-230B22.1 |
|
916 |
0.45 |
chr1_172109224_172109375 | 0.82 |
ENSG00000207949 |
. |
1252 |
0.44 |
chr11_94182402_94182553 | 0.81 |
ENSG00000221230 |
. |
17269 |
0.13 |
chr9_95298144_95298315 | 0.81 |
ECM2 |
extracellular matrix protein 2, female organ and adipocyte specific |
25 |
0.98 |
chr4_187648403_187648661 | 0.81 |
FAT1 |
FAT atypical cadherin 1 |
656 |
0.82 |
chr14_80678181_80678374 | 0.80 |
DIO2 |
deiodinase, iodothyronine, type II |
244 |
0.75 |
chr13_75150084_75150294 | 0.80 |
LINC00381 |
long intergenic non-protein coding RNA 381 |
156879 |
0.04 |
chr6_138427325_138427625 | 0.80 |
PERP |
PERP, TP53 apoptosis effector |
1173 |
0.59 |
chr17_37856067_37857084 | 0.80 |
ERBB2 |
v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 |
242 |
0.86 |
chr6_100909413_100909564 | 0.79 |
SIM1 |
single-minded family bHLH transcription factor 1 |
2065 |
0.42 |
chr20_57233106_57233257 | 0.79 |
STX16 |
syntaxin 16 |
6118 |
0.17 |
chr2_18157972_18158481 | 0.79 |
ENSG00000212455 |
. |
63773 |
0.13 |
chr20_10579322_10579500 | 0.79 |
JAG1 |
jagged 1 |
63743 |
0.13 |
chr19_50193963_50194180 | 0.78 |
CTB-33G10.6 |
|
241 |
0.5 |
chr13_33803329_33803516 | 0.78 |
STARD13 |
StAR-related lipid transfer (START) domain containing 13 |
23279 |
0.2 |
chr3_112355873_112356097 | 0.78 |
CCDC80 |
coiled-coil domain containing 80 |
959 |
0.65 |
chr2_69244565_69244720 | 0.78 |
ANTXR1 |
anthrax toxin receptor 1 |
4113 |
0.25 |
chr15_91006991_91007196 | 0.78 |
RP11-154B12.3 |
|
65980 |
0.08 |
chr4_16900577_16901013 | 0.78 |
LDB2 |
LIM domain binding 2 |
363 |
0.93 |
chr2_176995490_176995715 | 0.78 |
HOXD8 |
homeobox D8 |
517 |
0.55 |
chr1_220701624_220702485 | 0.78 |
MARK1 |
MAP/microtubule affinity-regulating kinase 1 |
155 |
0.97 |
chr9_73483733_73483949 | 0.77 |
TRPM3 |
transient receptor potential cation channel, subfamily M, member 3 |
98 |
0.98 |
chr6_137442626_137442884 | 0.77 |
IL22RA2 |
interleukin 22 receptor, alpha 2 |
52030 |
0.14 |
chr7_27217830_27218176 | 0.77 |
RP1-170O19.20 |
Uncharacterized protein |
1629 |
0.13 |
chr4_26577939_26578090 | 0.77 |
TBC1D19 |
TBC1 domain family, member 19 |
45 |
0.98 |
chr2_134432019_134432170 | 0.76 |
ENSG00000200708 |
. |
78432 |
0.11 |
chr2_56412283_56412467 | 0.75 |
AC007743.1 |
|
327 |
0.83 |
chr8_119344627_119344778 | 0.75 |
AC023590.1 |
Uncharacterized protein |
50221 |
0.19 |
chr5_92919468_92919846 | 0.75 |
NR2F1 |
nuclear receptor subfamily 2, group F, member 1 |
614 |
0.69 |
chr7_134474351_134474502 | 0.75 |
CALD1 |
caldesmon 1 |
9997 |
0.29 |
chr17_79609293_79609648 | 0.75 |
TSPAN10 |
tetraspanin 10 |
121 |
0.91 |
chr13_102151652_102151813 | 0.75 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
9429 |
0.3 |
chr3_110132950_110133243 | 0.75 |
ENSG00000221206 |
. |
137716 |
0.05 |
chr18_57385985_57386276 | 0.75 |
CCBE1 |
collagen and calcium binding EGF domains 1 |
21518 |
0.16 |
chr1_210405641_210405792 | 0.75 |
SERTAD4 |
SERTA domain containing 4 |
428 |
0.6 |
chr12_76271592_76272084 | 0.75 |
ENSG00000243420 |
. |
80072 |
0.1 |
chr9_86875979_86876265 | 0.74 |
RP11-380F14.2 |
|
17012 |
0.26 |
chr3_100784704_100784898 | 0.74 |
ABI3BP |
ABI family, member 3 (NESH) binding protein |
72442 |
0.11 |
chr11_8889856_8890095 | 0.74 |
ST5 |
suppression of tumorigenicity 5 |
2489 |
0.19 |
chr17_13965501_13965785 | 0.74 |
ENSG00000236088 |
. |
7132 |
0.24 |
chr1_94159203_94159501 | 0.73 |
BCAR3 |
breast cancer anti-estrogen resistance 3 |
11967 |
0.24 |
chr6_150173382_150173533 | 0.73 |
RP11-350J20.12 |
|
141 |
0.93 |
chr17_13266074_13266343 | 0.73 |
ENSG00000266115 |
. |
137437 |
0.05 |
chr6_148664824_148664993 | 0.73 |
SASH1 |
SAM and SH3 domain containing 1 |
1179 |
0.59 |
chr2_175854784_175854957 | 0.73 |
ENSG00000201425 |
. |
12339 |
0.15 |
chr10_33626258_33626516 | 0.73 |
NRP1 |
neuropilin 1 |
1197 |
0.6 |
chr6_133890397_133891036 | 0.73 |
RP3-323P13.2 |
|
57850 |
0.15 |
chr1_240760211_240760638 | 0.73 |
RP11-467I20.6 |
|
6376 |
0.21 |
chr4_52903753_52904199 | 0.73 |
SGCB |
sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) |
449 |
0.84 |
chr17_46651973_46652199 | 0.73 |
HOXB3 |
homeobox B3 |
237 |
0.8 |
chr15_74222319_74222668 | 0.72 |
LOXL1-AS1 |
LOXL1 antisense RNA 1 |
1904 |
0.26 |
chr12_26112779_26113361 | 0.72 |
RASSF8-AS1 |
RASSF8 atnisense RNA 1 |
372 |
0.8 |
chr3_147648289_147648638 | 0.72 |
ENSG00000221431 |
. |
19175 |
0.29 |
chr1_240258821_240259228 | 0.72 |
FMN2 |
formin 2 |
3844 |
0.31 |
chr5_40915264_40915466 | 0.72 |
ENSG00000253098 |
. |
4135 |
0.21 |
chr6_31082599_31082878 | 0.72 |
PSORS1C1 |
psoriasis susceptibility 1 candidate 1 |
130 |
0.91 |
chr10_48336328_48336544 | 0.72 |
ZNF488 |
zinc finger protein 488 |
18588 |
0.14 |
chr7_41926126_41926481 | 0.71 |
AC005027.3 |
|
181370 |
0.03 |
chr1_245255499_245255650 | 0.71 |
EFCAB2 |
EF-hand calcium binding domain 2 |
8816 |
0.18 |
chr1_97610415_97610576 | 0.71 |
DPYD-AS1 |
DPYD antisense RNA 1 |
49016 |
0.19 |
chr1_78005180_78005370 | 0.71 |
AK5 |
adenylate kinase 5 |
7483 |
0.25 |
chr19_49561050_49561269 | 0.71 |
CGB7 |
chorionic gonadotropin, beta polypeptide 7 |
151 |
0.85 |
chr12_85305306_85305778 | 0.71 |
SLC6A15 |
solute carrier family 6 (neutral amino acid transporter), member 15 |
261 |
0.96 |
chr4_151062450_151062706 | 0.71 |
DCLK2 |
doublecortin-like kinase 2 |
62398 |
0.13 |
chr4_123751095_123751246 | 0.71 |
ENSG00000253069 |
. |
3001 |
0.24 |
chr1_8433877_8434267 | 0.71 |
RERE |
arginine-glutamic acid dipeptide (RE) repeats |
9174 |
0.19 |
chr14_29705884_29706116 | 0.71 |
ENSG00000257522 |
. |
141862 |
0.05 |
chrX_100740463_100741131 | 0.71 |
ARMCX4 |
armadillo repeat containing, X-linked 4 |
2234 |
0.26 |
chr2_191511664_191511958 | 0.71 |
NAB1 |
NGFI-A binding protein 1 (EGR1 binding protein 1) |
339 |
0.9 |
chr5_56834430_56834632 | 0.70 |
ACTBL2 |
actin, beta-like 2 |
55895 |
0.13 |
chr10_95240803_95240954 | 0.70 |
MYOF |
myoferlin |
1073 |
0.51 |
chr13_113832243_113832413 | 0.70 |
RP11-98F14.11 |
|
12831 |
0.12 |
chr6_117852473_117852851 | 0.70 |
DCBLD1 |
discoidin, CUB and LCCL domain containing 1 |
48837 |
0.12 |
chr2_24398374_24398902 | 0.70 |
FAM228A |
family with sequence similarity 228, member A |
284 |
0.75 |
chr5_91977319_91977616 | 0.70 |
ENSG00000221810 |
. |
75753 |
0.13 |
chr19_16179581_16179939 | 0.69 |
TPM4 |
tropomyosin 4 |
1250 |
0.44 |
chr5_34658039_34658190 | 0.69 |
CTD-2024P10.1 |
|
759 |
0.56 |
chr4_55945978_55946129 | 0.69 |
ENSG00000244034 |
. |
16151 |
0.17 |
chr3_13421009_13421370 | 0.69 |
NUP210 |
nucleoporin 210kDa |
40620 |
0.18 |
chr3_134125279_134125630 | 0.69 |
ENSG00000221313 |
. |
3528 |
0.24 |
chr6_150218005_150218162 | 0.69 |
RAET1E |
retinoic acid early transcript 1E |
888 |
0.45 |
chr4_81195528_81195918 | 0.69 |
FGF5 |
fibroblast growth factor 5 |
7930 |
0.26 |
chr10_17275800_17275972 | 0.69 |
RP11-124N14.3 |
|
946 |
0.49 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.9 | GO:0070141 | response to UV-A(GO:0070141) |
0.4 | 1.7 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.4 | 1.3 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.4 | 1.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.4 | 1.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.4 | 1.1 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) glossopharyngeal nerve morphogenesis(GO:0021615) |
0.4 | 1.1 | GO:0031946 | regulation of glucocorticoid biosynthetic process(GO:0031946) |
0.3 | 0.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.3 | 1.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 1.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.3 | 0.9 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.3 | 1.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.3 | 0.8 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.3 | 1.0 | GO:0003211 | cardiac chamber formation(GO:0003207) cardiac ventricle formation(GO:0003211) |
0.3 | 1.0 | GO:0009169 | purine nucleoside monophosphate catabolic process(GO:0009128) ribonucleoside monophosphate catabolic process(GO:0009158) purine ribonucleoside monophosphate catabolic process(GO:0009169) |
0.2 | 0.7 | GO:0015820 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.2 | 0.9 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.2 | 0.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 0.6 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 1.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.2 | 0.4 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 0.8 | GO:0008218 | bioluminescence(GO:0008218) |
0.2 | 0.8 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.6 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.2 | 0.4 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 0.5 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.2 | 0.9 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.2 | 0.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.2 | 0.5 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.1 | 0.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.4 | GO:0060502 | epithelial cell proliferation involved in lung morphogenesis(GO:0060502) |
0.1 | 0.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.1 | 0.4 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 0.3 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 1.5 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 0.5 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 0.3 | GO:0072161 | mesenchymal cell differentiation involved in kidney development(GO:0072161) metanephric mesenchymal cell differentiation(GO:0072162) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.8 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
0.1 | 0.6 | GO:0070474 | uterine smooth muscle contraction(GO:0070471) regulation of uterine smooth muscle contraction(GO:0070472) positive regulation of uterine smooth muscle contraction(GO:0070474) |
0.1 | 1.3 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.1 | 0.9 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.7 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 0.4 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.1 | 3.1 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.1 | 0.4 | GO:1903053 | regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.1 | 0.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.7 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 0.3 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.1 | 0.3 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 1.2 | GO:0001660 | fever generation(GO:0001660) |
0.1 | 0.3 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.1 | 0.5 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.1 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.4 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.4 | GO:0055057 | neuronal stem cell division(GO:0036445) neuroblast division(GO:0055057) |
0.1 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.3 | GO:0010664 | striated muscle cell apoptotic process(GO:0010658) cardiac muscle cell apoptotic process(GO:0010659) regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
0.1 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.7 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.1 | 0.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.1 | 0.2 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.1 | 0.5 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.1 | 0.3 | GO:0035583 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.1 | 0.2 | GO:0010656 | negative regulation of muscle cell apoptotic process(GO:0010656) negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 0.3 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
0.1 | 0.4 | GO:0043206 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.1 | 0.6 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.1 | 0.3 | GO:0051182 | coenzyme transport(GO:0051182) |
0.1 | 1.3 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.1 | 0.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 0.2 | GO:0060737 | prostate gland morphogenetic growth(GO:0060737) |
0.1 | 0.6 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 0.2 | GO:0007350 | blastoderm segmentation(GO:0007350) |
0.1 | 0.1 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.2 | GO:0060536 | trachea cartilage morphogenesis(GO:0060535) cartilage morphogenesis(GO:0060536) |
0.1 | 0.7 | GO:0032456 | endocytic recycling(GO:0032456) |
0.1 | 1.1 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
0.1 | 0.2 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.1 | 0.2 | GO:0060013 | righting reflex(GO:0060013) |
0.1 | 0.4 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 1.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.7 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.1 | 0.2 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.1 | 0.3 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 0.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 | 0.3 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.1 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.1 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.1 | 0.3 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 | 0.3 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.1 | 0.2 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.3 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.1 | 0.3 | GO:0015889 | cobalamin transport(GO:0015889) |
0.1 | 0.1 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.6 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.3 | GO:0032288 | myelin assembly(GO:0032288) |
0.1 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0060677 | ureteric bud elongation(GO:0060677) |
0.1 | 0.2 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.1 | 0.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.2 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.1 | 0.1 | GO:1903672 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 0.1 | GO:0010837 | regulation of keratinocyte proliferation(GO:0010837) |
0.1 | 0.2 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.1 | 0.1 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 0.7 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.1 | 0.1 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
0.1 | 0.9 | GO:0008038 | neuron recognition(GO:0008038) |
0.1 | 0.2 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
0.1 | 0.5 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.2 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0030488 | tRNA methylation(GO:0030488) |
0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 0.1 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
0.1 | 0.1 | GO:2000050 | regulation of non-canonical Wnt signaling pathway(GO:2000050) |
0.1 | 1.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 0.1 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.2 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.1 | 0.3 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
0.1 | 0.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.1 | 0.1 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.1 | 0.4 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.1 | 0.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
0.1 | 0.2 | GO:0090292 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.1 | 0.4 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.1 | 0.2 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.1 | 0.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.1 | 0.1 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.0 | 1.1 | GO:0051925 | obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
0.0 | 1.0 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.0 | 0.3 | GO:0035088 | establishment or maintenance of apical/basal cell polarity(GO:0035088) establishment or maintenance of bipolar cell polarity(GO:0061245) |
0.0 | 0.0 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.0 | GO:0060435 | bronchiole development(GO:0060435) |
0.0 | 0.5 | GO:0031103 | axon regeneration(GO:0031103) |
0.0 | 0.1 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.5 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 2.1 | GO:0001764 | neuron migration(GO:0001764) |
0.0 | 0.9 | GO:0008589 | regulation of smoothened signaling pathway(GO:0008589) |
0.0 | 0.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.4 | GO:0043113 | receptor clustering(GO:0043113) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.7 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.0 | 0.1 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) positive regulation of pigment cell differentiation(GO:0050942) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.0 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.1 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.0 | 0.1 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.0 | 0.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.1 | GO:0030573 | bile acid catabolic process(GO:0030573) |
0.0 | 0.2 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.0 | 0.0 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 0.2 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.1 | GO:0043129 | surfactant homeostasis(GO:0043129) chemical homeostasis within a tissue(GO:0048875) |
0.0 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.0 | 0.8 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 5.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.1 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.0 | 0.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.0 | 0.2 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.0 | 0.1 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.0 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 0.0 | GO:0060296 | regulation of cilium movement(GO:0003352) regulation of cilium beat frequency(GO:0003356) cilium movement involved in cell motility(GO:0060294) regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.2 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.4 | GO:0071445 | obsolete cellular response to protein stimulus(GO:0071445) |
0.0 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.2 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.0 | 0.0 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.0 | 0.1 | GO:0060179 | male courtship behavior(GO:0008049) male mating behavior(GO:0060179) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
0.0 | 0.1 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.0 | 0.0 | GO:0032413 | negative regulation of ion transmembrane transporter activity(GO:0032413) |
0.0 | 0.3 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.0 | 0.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.1 | GO:0007492 | endoderm development(GO:0007492) |
0.0 | 0.1 | GO:0003321 | positive regulation of blood pressure by epinephrine-norepinephrine(GO:0003321) |
0.0 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.3 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.0 | 0.2 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.0 | 0.8 | GO:0001843 | neural tube closure(GO:0001843) tube closure(GO:0060606) |
0.0 | 0.0 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.0 | 0.6 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.0 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.4 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.0 | 0.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0021511 | spinal cord patterning(GO:0021511) |
0.0 | 0.1 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.0 | 0.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.0 | 0.1 | GO:0048048 | embryonic eye morphogenesis(GO:0048048) |
0.0 | 0.1 | GO:0001547 | antral ovarian follicle growth(GO:0001547) |
0.0 | 0.1 | GO:0050922 | negative regulation of chemotaxis(GO:0050922) |
0.0 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.1 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.3 | GO:0017015 | regulation of transforming growth factor beta receptor signaling pathway(GO:0017015) regulation of cellular response to transforming growth factor beta stimulus(GO:1903844) |
0.0 | 0.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.0 | 0.0 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
0.0 | 0.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.0 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:0010092 | specification of organ identity(GO:0010092) |
0.0 | 0.3 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.0 | 0.1 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
0.0 | 0.2 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
0.0 | 0.3 | GO:0014075 | response to amine(GO:0014075) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:2000171 | negative regulation of dendrite morphogenesis(GO:0050774) negative regulation of dendrite development(GO:2000171) |
0.0 | 1.0 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.2 | GO:0009437 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.0 | 0.0 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.1 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.0 | 0.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.0 | 0.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
0.0 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.0 | 0.2 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 0.0 | GO:0048319 | axial mesoderm development(GO:0048318) axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.0 | 0.4 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
0.0 | 0.2 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
0.0 | 0.1 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0043502 | regulation of muscle adaptation(GO:0043502) |
0.0 | 0.1 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.1 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.1 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.0 | 0.0 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.0 | 0.4 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.4 | GO:0007566 | embryo implantation(GO:0007566) |
0.0 | 0.1 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.0 | 0.1 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.0 | 0.2 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.1 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
0.0 | 0.1 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.2 | GO:0014068 | positive regulation of phosphatidylinositol 3-kinase signaling(GO:0014068) |
0.0 | 0.2 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.3 | GO:0030512 | negative regulation of transforming growth factor beta receptor signaling pathway(GO:0030512) negative regulation of cellular response to transforming growth factor beta stimulus(GO:1903845) |
0.0 | 0.0 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.0 | 0.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.0 | 0.0 | GO:0044268 | regulation of angiotensin levels in blood(GO:0002002) multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) multicellular organismal protein metabolic process(GO:0044268) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.0 | GO:0060442 | branching involved in prostate gland morphogenesis(GO:0060442) |
0.0 | 0.0 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.0 | 0.0 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.1 | GO:0044065 | regulation of respiratory system process(GO:0044065) |
0.0 | 0.0 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
0.0 | 0.1 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.0 | 0.0 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
0.0 | 0.0 | GO:0031102 | neuron projection regeneration(GO:0031102) |
0.0 | 0.1 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.1 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
0.0 | 0.1 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.6 | GO:0007368 | determination of left/right symmetry(GO:0007368) |
0.0 | 0.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.1 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.2 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.0 | 0.1 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.0 | 0.1 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.0 | 0.1 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.1 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.0 | 0.0 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.0 | 0.1 | GO:0060088 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 0.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.0 | 0.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
0.0 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) response to water(GO:0009415) |
0.0 | 0.1 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.1 | GO:1902749 | regulation of G2/M transition of mitotic cell cycle(GO:0010389) regulation of cell cycle G2/M phase transition(GO:1902749) |
0.0 | 0.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.4 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.0 | GO:0051503 | purine nucleotide transport(GO:0015865) adenine nucleotide transport(GO:0051503) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.1 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.0 | 0.9 | GO:0009408 | response to heat(GO:0009408) |
0.0 | 0.0 | GO:0016559 | peroxisome fission(GO:0016559) |
0.0 | 0.0 | GO:0072111 | cell proliferation involved in kidney development(GO:0072111) |
0.0 | 0.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.2 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.0 | 0.4 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.0 | 0.1 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.0 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.0 | GO:0009125 | nucleoside monophosphate catabolic process(GO:0009125) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.1 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.0 | GO:2000644 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
0.0 | 0.1 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.0 | 0.2 | GO:0072164 | ureteric bud development(GO:0001657) mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
0.0 | 0.0 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.3 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.0 | 0.0 | GO:0034371 | chylomicron remodeling(GO:0034371) |
0.0 | 0.2 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.0 | 0.0 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0032964 | collagen biosynthetic process(GO:0032964) |
0.0 | 0.0 | GO:0070254 | mucus secretion(GO:0070254) |
0.0 | 0.1 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.4 | GO:0010001 | glial cell differentiation(GO:0010001) |
0.0 | 0.1 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.0 | 0.0 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0032236 | obsolete positive regulation of calcium ion transport via store-operated calcium channel activity(GO:0032236) |
0.0 | 0.1 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.0 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.3 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.0 | GO:0046015 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.0 | 0.0 | GO:0000422 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
0.0 | 0.0 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.0 | 0.1 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
0.0 | 0.1 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.0 | 1.5 | GO:0007517 | muscle organ development(GO:0007517) |
0.0 | 0.1 | GO:0010955 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.0 | 0.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:1902101 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
0.0 | 0.1 | GO:0007422 | peripheral nervous system development(GO:0007422) |
0.0 | 0.0 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.0 | 0.0 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0033189 | response to vitamin A(GO:0033189) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.0 | GO:0007379 | segment specification(GO:0007379) |
0.0 | 0.2 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.1 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.0 | GO:0048806 | genitalia development(GO:0048806) |
0.0 | 0.0 | GO:0072112 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
0.0 | 0.0 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.0 | 0.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.3 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.0 | 0.1 | GO:0007628 | adult walking behavior(GO:0007628) walking behavior(GO:0090659) |
0.0 | 0.1 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.0 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) |
0.0 | 0.0 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
0.0 | 0.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
0.0 | 1.8 | GO:0006813 | potassium ion transport(GO:0006813) |
0.0 | 0.1 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.1 | GO:0050773 | regulation of dendrite development(GO:0050773) |
0.0 | 0.0 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.0 | 0.0 | GO:0014015 | positive regulation of gliogenesis(GO:0014015) |
0.0 | 0.0 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.0 | 0.1 | GO:0042246 | tissue regeneration(GO:0042246) |
0.0 | 0.0 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.0 | 0.0 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.0 | 0.0 | GO:0000470 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.0 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.0 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.0 | 0.0 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.0 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) |
0.0 | 0.1 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.0 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.7 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 1.8 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.3 | 1.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.3 | 1.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 0.7 | GO:0043260 | laminin-11 complex(GO:0043260) |
0.2 | 0.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 0.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.2 | 0.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.2 | 1.2 | GO:0030128 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.7 | GO:0071437 | invadopodium(GO:0071437) |
0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 0.5 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.1 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 1.0 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 1.2 | GO:0043205 | fibril(GO:0043205) |
0.1 | 0.7 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 0.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.8 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.3 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.1 | 0.6 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.3 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.6 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.1 | 0.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.2 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.4 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.2 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.1 | 0.2 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 1.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
0.0 | 0.8 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 4.6 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 1.0 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.0 | 1.0 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 2.8 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.4 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
0.0 | 0.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 2.4 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.9 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 4.9 | GO:0005911 | cell-cell junction(GO:0005911) |
0.0 | 0.9 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 7.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 0.1 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.0 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.0 | 0.6 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.0 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 3.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 0.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.5 | GO:0030118 | clathrin coat(GO:0030118) |
0.0 | 0.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.1 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
0.0 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.0 | 0.1 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.2 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 0.2 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.0 | 1.3 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.0 | 0.0 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.1 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.0 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.1 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.2 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.0 | 0.0 | GO:0032449 | CBM complex(GO:0032449) |
0.0 | 0.0 | GO:0032806 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) carboxy-terminal domain protein kinase complex(GO:0032806) |
0.0 | 0.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 3.3 | GO:0031012 | extracellular matrix(GO:0031012) |
0.0 | 0.0 | GO:0070545 | PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.0 | GO:0031501 | mannosyltransferase complex(GO:0031501) dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.5 | 1.4 | GO:0000987 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) core promoter proximal region sequence-specific DNA binding(GO:0000987) core promoter proximal region DNA binding(GO:0001159) |
0.3 | 1.0 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.3 | 1.0 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 1.0 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.3 | 1.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.3 | 0.9 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 1.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.2 | 0.7 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.2 | 1.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 0.8 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
0.2 | 1.2 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.2 | 0.5 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 0.7 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.2 | 1.0 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.2 | 0.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.2 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.1 | 0.4 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 1.2 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 1.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.4 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
0.1 | 0.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
0.1 | 0.4 | GO:0005346 | purine ribonucleotide transmembrane transporter activity(GO:0005346) |
0.1 | 0.8 | GO:0051636 | obsolete Gram-negative bacterial cell surface binding(GO:0051636) |
0.1 | 0.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.1 | 0.4 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.1 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 1.0 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.3 | GO:0031705 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
0.1 | 3.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.1 | 0.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 1.5 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.1 | 0.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.1 | 0.3 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.1 | 0.2 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.1 | 0.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.3 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 0.2 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.1 | 0.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.1 | 0.8 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.1 | 0.5 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.2 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.2 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
0.1 | 0.2 | GO:0035252 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.2 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.2 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.1 | 0.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.1 | 0.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 0.3 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 0.9 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.6 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.8 | GO:0045296 | cadherin binding(GO:0045296) |
0.0 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.9 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.0 | 0.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.0 | 0.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.3 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.2 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.0 | 0.0 | GO:0000976 | transcription regulatory region sequence-specific DNA binding(GO:0000976) |
0.0 | 0.1 | GO:0052659 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity(GO:0052659) |
0.0 | 0.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.2 | GO:0009374 | biotin binding(GO:0009374) |
0.0 | 1.6 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 1.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 0.1 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 0.5 | GO:0016918 | retinal binding(GO:0016918) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.1 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.0 | 0.1 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.1 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.0 | 0.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.4 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 1.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.1 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.0 | 0.1 | GO:0004470 | malic enzyme activity(GO:0004470) |
0.0 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 0.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.3 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.0 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.2 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.1 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
0.0 | 0.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.0 | 0.2 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.0 | 8.2 | GO:0030528 | obsolete transcription regulator activity(GO:0030528) |
0.0 | 0.1 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
0.0 | 0.1 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.0 | 0.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.0 | 0.1 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.4 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 0.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.3 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.0 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.0 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
0.0 | 0.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.2 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.1 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.0 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.0 | 0.3 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 1.8 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.0 | 0.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.0 | 0.1 | GO:0004083 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.0 | 0.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.0 | 2.0 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
0.0 | 0.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.0 | 0.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.0 | 0.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.0 | 0.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 0.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.0 | 0.0 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.1 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.0 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.0 | 1.1 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 1.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.0 | 0.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.0 | 0.1 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 0.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.0 | 0.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.4 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
0.0 | 0.1 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 0.1 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.0 | 0.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.0 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.0 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.0 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.0 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.6 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 0.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
0.0 | 0.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.0 | 0.3 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 1.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.0 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.0 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.0 | 0.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.0 | 0.1 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.0 | 0.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.0 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.0 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.0 | 5.9 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.0 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.0 | 0.1 | GO:0030506 | ankyrin binding(GO:0030506) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.1 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.1 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.0 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.4 | GO:0019902 | phosphatase binding(GO:0019902) |
0.0 | 0.0 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0001077 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.0 | 0.0 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.0 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.0 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.0 | GO:0030546 | receptor activator activity(GO:0030546) |
0.0 | 0.0 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.0 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 5.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.1 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 1.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 1.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 1.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.9 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 1.2 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.1 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 5.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 0.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.5 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 0.2 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.5 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.4 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 1.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 1.0 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 0.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.2 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.3 | PID FGF PATHWAY | FGF signaling pathway |
0.0 | 3.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.2 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.0 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.2 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.0 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.3 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 0.2 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 3.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 3.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.9 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.0 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.1 | 1.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 3.3 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.1 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.1 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 2.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 1.5 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.6 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 0.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 0.1 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.1 | 0.7 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.1 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 0.8 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 0.8 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.0 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.5 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.0 | 0.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 1.5 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
0.0 | 0.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.0 | 0.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.2 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.0 | 0.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.0 | 0.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 0.4 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.0 | 0.3 | REACTOME GABA RECEPTOR ACTIVATION | Genes involved in GABA receptor activation |
0.0 | 0.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.0 | 0.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.1 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.2 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.0 | 0.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.2 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.0 | 0.2 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.4 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.0 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.2 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.0 | 0.0 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 0.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.2 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.2 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.0 | 0.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 0.1 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.0 | 0.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.0 | 0.2 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |